Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

co.don

co.don
1999 FOUNDED
PUBLIC STATUS
91-100 EMPLOYEES
CNWK STOCK SYMBOL
$2.93 SHARE PRICE (As of Friday Closing)
Description

co.don AG in cell breeding for the joint-preserving treatment of articular cartilage damage. The company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures and dental disorders.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
ETR
Primary Office
  • Warthestra├če 21
  • 14513 Teltow
  • Germany

+49 03328 00000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore co.don’s full profile, request a free trial.

co.don Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.16 - $6.51 $62.6M $2.92 -$0.49 22.9K 21.4M

co.don Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 96,431 70,680 154,857 42,653
Revenue 6,645 6,672 7,134 6,192
EBITDA (9,432) (9,258) (6,823) (3,769)
Net Income (9,819) (7,400) (7,418) (4,037)
Total Assets 29,050 31,367 23,688 5,070
Total Debt 2,989 10,849 668 628
Public Fundamental Data provided by Morningstar, Inc. disclaimer